Diabetes News April 2nd 2010

Health Profile of England 2009
Rising rates of diabetes (DoH, UK)

Diabetes in the UK 2010
Key statistics on diabetes (Diabetes UK)

Scottish diabetes survey 2009
The Scottish Diabetes Survey provides data on the number of people with diabetes, the effects on their health, and the progress being made to improve the delivery and outcomes of care for diabetes (NHS, UK)

Management of diabetes
This guideline provides recommendations based on current evidence for best practice in the management of diabetes (NHS Evidence Diabetes)

Good clinical practice guidelines for care home residents with diabetes
A revision document prepared by a Task and Finish Group of (Diabetes UK)

Structure of insulin’s docking point identified
Walter and Eliza Hall Institute scientists have determined the structure of a previously unseen part of the insulin receptor, making possible new treatments for diabetes (Walter and Eliza Hall Institute)

Key Protein Links Insulin Action and Insulin Resistance in Diabetes
Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result—triggering a stress response that leads to insulin resistance ( Joslin Diabetes Center)

Novo Nordisk Bluesheet
Quarterly perspectives on diabetes and chronic diesases (Novo Nordisk)

Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes
Metformin-associated GI symptoms in patients with T2DM lead to lower physical and mental HRQoL, which may result in patient nonadherence or physician reluctance to optimally titrate the metformin dose (Postgraduate Medicine)

Sanofi-Aventis will move into diabetes glucose testing
The French drugmaker Sanofi-Aventis will broaden their healthcare resources on Wednesday by moving into an agreement to develop blood glucose monitors with AgaMatrix, a private American firm (Diabetes.co.uk)